JPS5946223A - 抗菌性組成物 - Google Patents
抗菌性組成物Info
- Publication number
- JPS5946223A JPS5946223A JP57150398A JP15039882A JPS5946223A JP S5946223 A JPS5946223 A JP S5946223A JP 57150398 A JP57150398 A JP 57150398A JP 15039882 A JP15039882 A JP 15039882A JP S5946223 A JPS5946223 A JP S5946223A
- Authority
- JP
- Japan
- Prior art keywords
- chitosan
- antibacterial composition
- page
- antibacterial
- sulfonamide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 15
- 239000000203 mixture Substances 0.000 title claims abstract description 14
- 229920001661 Chitosan Polymers 0.000 claims abstract description 17
- 150000003839 salts Chemical class 0.000 claims abstract description 7
- 229940124530 sulfonamide Drugs 0.000 claims abstract description 7
- 150000003456 sulfonamides Chemical class 0.000 claims abstract description 7
- JLKIGFTWXXRPMT-UHFFFAOYSA-N sulphamethoxazole Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 JLKIGFTWXXRPMT-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229960005404 sulfamethoxazole Drugs 0.000 claims abstract description 3
- 241000238557 Decapoda Species 0.000 abstract description 7
- 229920002101 Chitin Polymers 0.000 abstract description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 abstract description 6
- 239000000243 solution Substances 0.000 abstract description 5
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 abstract description 2
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 abstract description 2
- 239000007864 aqueous solution Substances 0.000 abstract description 2
- 229950006780 n-acetylglucosamine Drugs 0.000 abstract description 2
- 229920001282 polysaccharide Polymers 0.000 abstract description 2
- 239000005017 polysaccharide Substances 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract description 2
- 230000000850 deacetylating effect Effects 0.000 abstract 1
- 150000004676 glycans Chemical class 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 230000002301 combined effect Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- 241000238424 Crustacea Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- IEDVJHCEMCRBQM-UHFFFAOYSA-N trimethoprim Chemical compound COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 IEDVJHCEMCRBQM-UHFFFAOYSA-N 0.000 description 2
- 229960001082 trimethoprim Drugs 0.000 description 2
- XUKUURHRXDUEBC-KAYWLYCHSA-N Atorvastatin Chemical compound C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-KAYWLYCHSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- -1 acid amide compounds Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229940000425 combination drug Drugs 0.000 description 1
- 229940003898 combination of sulfonamides Drugs 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- QXJQHYBHAIHNGG-UHFFFAOYSA-N trimethylolethane Chemical compound OCC(C)(CO)CO QXJQHYBHAIHNGG-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57150398A JPS5946223A (ja) | 1982-08-30 | 1982-08-30 | 抗菌性組成物 |
| EP83107071A EP0105106B1 (en) | 1982-08-30 | 1983-07-19 | Anti-bacterial composition |
| DE8383107071T DE3381943D1 (de) | 1982-08-30 | 1983-07-19 | Bakterizide zusammensetzung. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57150398A JPS5946223A (ja) | 1982-08-30 | 1982-08-30 | 抗菌性組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5946223A true JPS5946223A (ja) | 1984-03-15 |
| JPH0372043B2 JPH0372043B2 (enExample) | 1991-11-15 |
Family
ID=15496102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP57150398A Granted JPS5946223A (ja) | 1982-08-30 | 1982-08-30 | 抗菌性組成物 |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP0105106B1 (enExample) |
| JP (1) | JPS5946223A (enExample) |
| DE (1) | DE3381943D1 (enExample) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995020968A1 (en) * | 1992-08-07 | 1995-08-10 | Nippon Soda Co., Ltd. | Prophylatic for domestic animal mastitis |
| US6352727B1 (en) | 1998-03-12 | 2002-03-05 | Oji Paper Co., Ltd. | Bactericides |
| WO2015129564A1 (ja) * | 2014-02-27 | 2015-09-03 | 一般社団法人グリーンエバー | サルファ剤およびキトサン剤を含む、発毛および／または育毛促進組成物 |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1261264A (en) * | 1984-11-29 | 1989-09-26 | Shigeo Suzuki | Immunopotentiating agents and method |
| GB8706052D0 (en) * | 1987-03-13 | 1987-04-15 | Medical Research Int | Therapeutic compositions |
| US6306835B1 (en) | 1997-09-23 | 2001-10-23 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Biocidal chitosan derivatives |
| EP3087990B1 (en) * | 2013-12-24 | 2020-05-06 | Greenever | Gel-forming powder comprising sulfamonomethoxine and chitosan for treating wounds |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1252373A (enExample) * | 1969-02-03 | 1971-11-03 | ||
| JPS57109713A (en) * | 1980-12-26 | 1982-07-08 | Shionogi & Co Ltd | Pharmaceutical preparation of combined agent of sulfamethoxazole and trimethoprim for medication through celom |
-
1982
- 1982-08-30 JP JP57150398A patent/JPS5946223A/ja active Granted
-
1983
- 1983-07-19 DE DE8383107071T patent/DE3381943D1/de not_active Expired - Fee Related
- 1983-07-19 EP EP83107071A patent/EP0105106B1/en not_active Expired - Lifetime
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995020968A1 (en) * | 1992-08-07 | 1995-08-10 | Nippon Soda Co., Ltd. | Prophylatic for domestic animal mastitis |
| US6352727B1 (en) | 1998-03-12 | 2002-03-05 | Oji Paper Co., Ltd. | Bactericides |
| WO2015129564A1 (ja) * | 2014-02-27 | 2015-09-03 | 一般社団法人グリーンエバー | サルファ剤およびキトサン剤を含む、発毛および／または育毛促進組成物 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP0105106A3 (en) | 1986-07-16 |
| EP0105106A2 (en) | 1984-04-11 |
| EP0105106B1 (en) | 1990-10-17 |
| JPH0372043B2 (enExample) | 1991-11-15 |
| DE3381943D1 (de) | 1990-11-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS60126220A (ja) | 核酸成分組成物 | |
| US5510387A (en) | Antimicrobial interferon-inducing medicament | |
| JPH04230631A (ja) | 二価金属イオンと複合体を形成した４−キノロン誘導体を含有する組成物 | |
| JPS5946223A (ja) | 抗菌性組成物 | |
| JPS62221630A (ja) | 人工唾液組成物 | |
| US4455305A (en) | Composition for the treatment of colitis ulcerosa, enteritis regionalis crohn (morbus crohn), chronic nonspecific colitis and diverticulitis and the use of salicylazobenzoic acid for the preparation of such compositions | |
| JPH0131390B2 (enExample) | ||
| Barillo | Topical antimicrobials in burn wound care: a recent history | |
| US3548052A (en) | Heparin compositions and methods of using same | |
| FR2609396A1 (fr) | Composition de sels et d'ion amphotere de cephalosporine lyophilisee ou precipitee | |
| US3985873A (en) | Solution containing trimethoprim, sulfacetamide and polymyxin | |
| JPH0469342A (ja) | 水性医薬製剤 | |
| JPH0352443B2 (enExample) | ||
| JP3769045B2 (ja) | 抗炎症剤 | |
| CA1154676A (en) | Ready for use, injectable, aqueous solutions of alkali metal salts of canrenoic acid and furosemide and process for their preparation | |
| JPS58134026A (ja) | 抗菌組成物およびその製法と用途 | |
| JP2008525415A (ja) | 炎症性疾患の治療 | |
| RU2360667C2 (ru) | Антибактериальное лекарственное средство для лечения и профилактики желудочно-кишечных болезней животных | |
| JPS5962523A (ja) | 抗腫瘍剤 | |
| US3981999A (en) | Fish disease treatment | |
| US3681493A (en) | Antibacterial compositions | |
| Itokawa et al. | Toxicity of polychlorinated biphenyls increased with simultaneous ingestion of alkylbenzene sulfonic acid salt | |
| EP0540945B1 (en) | Compositions comprising an isothiazole derivative and a peat-derived bioactive product | |
| JPS59222405A (ja) | 銀錯体を使用する抗微生物剤 | |
| US3574830A (en) | Process for inhibiting the transfer of antibiotic resistance determinants in bacteria |